Literature DB >> 10964599

Evidence for oxidative stress in experimental prion disease.

M Guentchev1, T Voigtländer, C Haberler, M H Groschup, H Budka.   

Abstract

Oxidative stress has been shown to be important in several neurodegenerative disorders. Previous in vitro studies have already demonstrated the ability of a prion protein fragment to induce oxidative stress in cultured cells. By immunohistochemistry for nitrotyrosine (NT) and heme oxygenase-1 as markers for oxidative stress, we found widespread neuronal labeling for NT in scrapie-infected mouse brains, in agreement with peroxynitrite mediated neuronal degeneration. Damage by free radicals is a likely cause for neurodegeneration in prion disease, and antioxidants are a potential therapy of these disorders. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964599     DOI: 10.1006/nbdi.2000.0290

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  22 in total

Review 1.  The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.

Authors:  Alessandra Gaeta; Robert C Hider
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 2.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

Review 3.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

Review 4.  Copper-dependent functions for the prion protein.

Authors:  David R Brown; Judyth Sassoon
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

5.  Proteolytic processing of the prion protein in health and disease.

Authors:  Hermann C Altmeppen; Berta Puig; Frank Dohler; Dana K Thurm; Clemens Falker; Susanne Krasemann; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

6.  Metal imbalance and compromised antioxidant function are early changes in prion disease.

Authors:  Alana M Thackray; Robert Knight; Stephen J Haswell; Raymond Bujdoso; David R Brown
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

7.  PrPSc Inhibition and Cellular Protection of DBL on a Prion-Infected Cultured Cell via Multiple Pathways.

Authors:  Wei Yang; Cao Chen; Jia Chen; Ying Xia; Chao Hu; Lin Wang; Yue-Zhang Wu; Qi Shi; Zhi-Bao Chen; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2022-03-18       Impact factor: 5.590

8.  Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease.

Authors:  Dilshan S Harischandra; Naveen Kondru; Dustin P Martin; Arthi Kanthasamy; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

9.  Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo.

Authors:  Ayodeji A Asuni; Maitea Guridi; Sandrine Sanchez; Martin J Sadowski
Journal:  Neurochem Int       Date:  2015-08-08       Impact factor: 3.921

10.  Prion protein accumulation and neuroprotection in hypoxic brain damage.

Authors:  Neil F McLennan; Paul M Brennan; Alisdair McNeill; Ioan Davies; Andrew Fotheringham; Kathleen A Rennison; Diane Ritchie; Francis Brannan; Mark W Head; James W Ironside; Alun Williams; Jeanne E Bell
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.